These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 1329248

  • 1. Treatment of relapse of small cell lung cancer in selected patients with the initial combination chemotherapy with carboplatin, etoposide and epirubicin.
    Nyman CR.
    Thorax; 1992 Aug; 47(8):668. PubMed ID: 1329248
    [No Abstract] [Full Text] [Related]

  • 2. Treatment of relapse of small cell lung cancer in selected patients with the initial combination chemotherapy carboplatin, etoposide, and epirubicin.
    Collard P, Weynants P, Francis C, Rodenstein DO.
    Thorax; 1992 May; 47(5):369-71. PubMed ID: 1319088
    [Abstract] [Full Text] [Related]

  • 3. Phase II study of intensive CEV (carboplatin, epirubicin and VP-16) plus G-CSF (granulocyte-colony stimulating factor) in extensive small cell lung cancer.
    Gridelli C, Perrone F, D'Aprile M, Rossi A, Palmeri S, Curcio C, Veltri E, Ianniello G, Lorusso V, Palmieri G.
    Eur J Cancer; 1995 Dec; 31A(13-14):2424-6. PubMed ID: 8652288
    [No Abstract] [Full Text] [Related]

  • 4. Use of high-dose etoposide/ifosfamide/carboplatin/epirubicin and peripheral blood progenitor cell transplantation in limited-disease small cell lung cancer.
    Brugger W, Frommhold H, Pressler K, Mertelsmann R, Kanz L.
    Semin Oncol; 1995 Feb; 22(1 Suppl 2):3-8. PubMed ID: 7531368
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Carboplatin/etoposide in small cell lung cancer.
    Bishop JF.
    Oncology; 1992 Feb; 49 Suppl 1():11-7; discussion 17-8. PubMed ID: 1323807
    [Abstract] [Full Text] [Related]

  • 7. Dose intensification of carboplatin and etoposide as first-line combination chemotherapy in small cell lung cancer.
    Ellis PA, Talbot DC, Priest K, Jones AL, Smith IE.
    Eur J Cancer; 1995 Oct; 31A(11):1888-9. PubMed ID: 8541123
    [No Abstract] [Full Text] [Related]

  • 8. Carboplatin in association with etoposide and either adriamycin or epirubicin for untreated small cell lung cancer: a dose escalation study of carboplatin. UCL Clinical Oncology Group.
    Humblet Y, Weynants P, Bosly A, Majois F, Duprez P, Francis C, Beauduin M, Machiels J, Gailly C, Delaunois L.
    Med Oncol Tumor Pharmacother; 1989 Oct; 6(3):207-12. PubMed ID: 2559261
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Can Carboplatin replace Cisplatin in small cell lung cancer?
    Noronha V.
    Indian J Cancer; 2011 Oct; 48(4):452-3. PubMed ID: 22293259
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Modified Ifosphamide/CarboPlatin/Etoposide.
    Snee MP.
    Clin Oncol (R Coll Radiol); 2003 May; 15(3):165; author reply 165. PubMed ID: 12801057
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Alternated approach with local irradiation and combination chemotherapy including cisplatin or carboplatin plus epirubicin and etoposide in intermediate stage non-small cell lung cancer.
    Le Péchoux C, Arriagada R, Le Chevalier T.
    Cancer; 1995 Aug 01; 76(3):530-1. PubMed ID: 8625139
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Chemotherapy for elderly SCLC patients.
    Satoh H, Ohtsuka M, Sekizawa K.
    Lung Cancer; 2003 Apr 01; 40(1):107. PubMed ID: 12660016
    [No Abstract] [Full Text] [Related]

  • 20. [Chemotherapy in extended small-cell lung cancer. Retrospective analysis of two different series of patients treated with carboplatin and etoposide or ciclophosphamide-epidoxorubicin and etoposide].
    Tassinari D, Genestreti G, Pasquini E, Fantini M, Poggi B, Tamburini E, Papi M, Ioli G, Oliverio G, Fochessati F, Arcangeli V, Agostini V, Mianulli AM, Imola M, Fattori PP, Ravaioli A.
    Recenti Prog Med; 2005 May 01; 96(5):234-9. PubMed ID: 15977652
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.